Heart failure & cardiomyopathies
Reduction in 90 Day Readmission Rates Utilizing Ambulatory Pulmonary Pressure Monitoring
Main finding · 90 day all-cause readmissionResult — go to the resultIncidence rate ratio 0.45 CI 0.35–0.58Authors' conclusion
Across a large hospital network, ambulatory haemodynamic monitoring was associated with lower HFH rates, as well as 30 and 90 day all-cause readmission rates.
Study context
- Population
- Patients with pulmonary artery pressure (PAP) sensor implantation across the Advocate Aurora Health network, Oct 2015–Oct 2019; prior ventricular assist device (VAD) or transplant excluded
- Participants
- 459 patients
- Exposure
- Post- vs pre-implantation of ambulatory PAP sensor
- Outcome
- 90 day all-cause readmission after HFH
- Follow-up
- Up to 12 months after implantation
Methodological detailsmulticentre hospital network, before-after comparison
- Multicentre hospital network
- Before-after comparison
Main finding
90 day all-cause readmission
Incidence rate ratio
0.45
CI 0.35–0.58
P < 0.0001
Post-implantationvs Pre-implantation
IRR 0.45 (CI 0.35–0.58); P < 0.0001
As reported in the abstract
Observational data: associations, not effects.
Further findings
| Outcome | IRR (CI) | P value | |
|---|---|---|---|
| 30-day all-cause readmission | 0.55 (0.39–0.77) | P = 0.0006 | |
| 0.20.5125Incidence rate ratio (log scale) |
Total heart failure hospitalization (HFH) · up to 12 months after implantation
- HFHs before implantation
- 404
- HFHs after implantation
- 179
90-day all-cause readmission, subgroups
- Effect consistent across multiple subgroups
Original publication
Reduction in 90 Day Readmission Rates Utilizing Ambulatory Pulmonary Pressure Monitoring. ESC Heart Fail. Published 27 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →